Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05725746 · ClinicalTrials.gov registry record
Feasibility of Remote Data Collection With a Point of Care Device to Measure HbA1c
A clinical trial, sponsored by Washington University School of Medicine.
- Completed
- Registry status
- 18
- Enrollment target
NCT05725746: Completed study, sponsored by Washington University School of Medicine.
NCT05725746 is a clinical trial that has completed, run by Washington University School of Medicine. The registered enrollment target is 18 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05725746 has completed, sponsored by Washington University School of Medicine.
- COMPLETED
- Registry status
- 18 participants
- Enrollment target
Study Summary
Conduct a pilot study to test feasibility of doing remote data collection with a point of care device that measures HbA1c.
Primary Outcome
Feasibility will be measured by how many participants are able to obtain HbA1c measure through remote data collection and participant's satisfaction with this means of data collection.
Interventions
- DIAGNOSTIC_TEST Point of care device to measure HbA1c
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 18 participants |
| Start Date | 2023-02-24 |
| Est. Completion | 2024-04-25 |
What the finished NCT05725746 record still lists
NCT05725746 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 18 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Point of care device to measure HbA1c is the first listed.
NCT05725746 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05725746 about?
NCT05725746 is a clinical study titled "Feasibility of Remote Data Collection With a Point of Care Device to Measure HbA1c". Conduct a pilot study to test feasibility of doing remote data collection with a point of care device that measures HbA1c.
What is the current status of trial NCT05725746?
This trial is currently completed. The enrollment target is 18 participants. The study started on 2023-02-24. Estimated completion is 2024-04-25.
What interventions are being tested in trial NCT05725746?
The interventions under investigation include: Point of care device to measure HbA1c (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT05725746?
This trial is sponsored by Washington University School of Medicine, which has 1,502 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01245179 · 18 participants · Phase 1
Study of Panobinostat (LBH589) in Patients With Sickle Cell Disease
- NCT01999361 · 18 participants · NA
Prevention of de Novo Allosensitization in Islet Transplant Recipients Following Complete Graft Loss
- NCT02359825 · 18 participants · Phase 1
Nerve Repair Using Hydrophilic Polymers to Promote Immediate Fusion of Severed Axons and Swift Return of Function
- NCT02870244 · 18 participants · Phase 1
Adoptive T Cell Immunotherapy for Advanced Melanoma Using Engineered Lymphocytes
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI